Oculeve, Inc. — Form D/A
Oculeve, Inc. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2013-03-20. The offering totals $7.6M, of which $7.6M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2013-03-20
- Form: D/A
- Accession: 0001533518-13-000001
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $7.6M
- Amount sold: $7.6M
- Remaining: $3K
- Investors: 9
- Date of first sale: 2012-10-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-186287
Issuer
- Name: Oculeve, Inc.
- CIK: 0001533518
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2011
- Address: 1082 PENNSYLVANIA AVE. #409, SAN FRANCISCO, CA, 94107
- Phone: 502-295-1587
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Mark Blumenkranz | Director | Menlo Park, CA |
| Brook Byers | Director | San Francisco, CA |
| William Link | Director | Corona Del Mar, CA |
| Ali Behbahani | Director | Littleton, CO |
| D. Michael Ackermann, PhD | Director | San Francisco, CA |
| D. Michael Ackermann, PhD | Executive Officer | San Francisco, CA |
| Steve J Waite | Director | South San Francisco, CA |
| Brook S Byers | Director | South San Francisco, CA |
| Mark S Blumenkranz, MD | Director | South San Francisco, CA |
| William J Link, PhD | Director | South San Francisco, CA |
| James J Loudin | Executive Officer | South San Francisco, CA |
Other filings by this issuer (5)
More